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Abstract
Background: Post burn pruritus is a syndrome of stressful symptoms that is pervasive and occurs in
over 90% of burn patients and continues for years after the burn has healed. Post burn pruritus is
experienced by burn survivors that may require medical management and effective interventions.
Purpose: This article is to show how to relieve post burn pruritus effectively by developing a post
burn pruritus relief protocol. Design: A descriptive literature review was conducted and relevant
empirical articles written during the year of 2000 to 2014 were appraised to create a post burn
pruritus relief protocol. Twenty seven out of 79 articles were selected using pre-established inclusion
criteria: any age group experiencing burn related pruritus after second or third degree burns. Data
bases were Cochrane Central Register of Controlled Trials, CINAHL, EBSCO, PubMed, the
National Guideline Clearinghouse, google scholar, and the American Burn Association web site.
Conclusions: This protocol included both non-pharmacological and pharmacological interventions
that have been delineated for use and was developed to apply based on the healing stage: pre-healing,
healing, and post-healing.
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Introduction
Post burn pruritus (PBP), a severe itching sensation associated with burn injury, has been
identified as one of the most debilitating symptoms post burn survivors experience (Ahuja,
Gupta, R., Gupta, G., & Shrivastava, 2011; Carrougher et al., 2013; Goutos, 2010; Goutos et al.,
2010; Otene & Omuma-egbu, 2013). Pruritus appears the first two weeks following burn injury
(Ahuja et al., 2011; Goutos et al., 2010). The prevalence of post burn pruritus has been noted in
over 90% of burn patients and can persist in greater than 40% of patients for four to ten years
after burn injury (Carrougher et al., 2013). Several studies showed the incidence of onset of post
burn pruritus varies from 80%-100% with the onset during the early healing phase and sustaining
for many years after injury (Ahuja & Gupta, 2013; Baker et al., 2001; Whitaker, 2001).
Research findings have recurrently proposed that PBP management should be one of the top
priorities for burn research (Bell & Gabriel, 2009; Brooks et al., 2008). Burn associated pruritus,
when persistent, can cause disabling symptoms such as sleep disturbances, anxiety, and
interruption in daily activities (Goutos et al., 2009).
Although pruritus in post burn patients is well recognized, there is no consensus on
standardized treatment (Bell & Gabriel, 2009; Otene & Onumaegbu, 2013; Richardson, Upton,
& Rippon, 2014). Single treatment may be ineffective, but most often therapies focus on either
pharmacological or non-pharmacological interventions. However, pharmacological
interventions have adverse effects in some population with kidney problems, liver diseases or
allergies to specific medicines, which causes pharmacological interventions to be limited to use.
Therefore, the purpose of conducting this literature review was to establish a protocol for PBP
relief with the integration of evidence based practices, primarily focused on non-pharmacological
interventions.
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Literature Search
A keyword search was performed to identify relevant literature via Cochrane Central
Register of Controlled Trials, CINAHL, EBSCO, PubMed, the National Guideline
Clearinghouse, google scholar, and the American Burn Association web site. The key words
were burn(s), itching, and pruritus. Due to limited publications, database searches were
expanded to all peer reviewed and published studies written in English during the year of 2000 to
2014, conducted with all second and third degree burn populations suffering from post-burn
related pruritus. As a result, 79 articles were initially listed from search engines and 26 out of 79
articles were found relevant to the purpose of this review, developing a post burn pruritus relief
protocol.
Results
The process of finalizing 26 relevant articles is shown through the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram (Figure 1). All
relevant articles for the treatment of PBP were summarized including the study design, setting,
result, and limitation (Table 1). Treatments are categorized in pharmacological and nonpharmacological interventions.
Pharmacological Interventions
Thirteen out of 26 articles identified pharmacological effects on PBP that included both
single oral medicine use and two or three combining oral medicine. Examples of effective oral
pharmacological interventions include 1) pregabalin (Lyrica®) alone; 2) gabapentin
(Neurontin®, Gralise®, Horizant®, Fanatrex FusePag®) alone; 3) pregabalin and two different
antihistamines (histamine1 [H1] and histamine2 [H2] blockers); 4) gabapentin and one
antihistamine (H1 blocker); 5) gabapentin and two different antihistamines; and 6) combination
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of two different antihistamines. According to the randomized controlled trial (RCT) by Ahuja
and Gupta (2013), pregabalin alone or combination of two kinds of antihistamines decreased
PBP but adding more antihistamines did not decrease PBP additionally. Gabapentin alone or
combination of one or two antihistamines reduced PBP in several studies (Ahuja et al., 2011;
Goutos et al., 2010; Mendham, 2004). Combination of two different antihistamines also lowered
PBP more than using one antihistamine (Baker et al., 2001). Two experimental studies show
naltrexone (Vivitrol®, Revia®, Depade®) is supportive in decreasing duration and frequency of
itching in patients with PBP and can be used before sleeping as a supplementary method to other
anti-pruritic medicine (Jung et al., 2009; LaSalle, Rachelska, & Nedelec, 2007).
Oral medications are more effective when given as scheduled than being given as needed
(Baker et al., 2001). However, oral pharmacological interventions have adverse effects. For
example, antihistamines are well known for drowsiness (Vallerand, Sanoski, & Deglin, 2016).
Pregabalin has withdrawal symptoms such as insomnia, headache, agitation, nausea, anxiety,
diarrhea, flu like symptoms, nervousness, major depression, pain, convulsions, hyperhidrosis,
and dizziness when abruptly stopped (Vallerand et al., 2016). In addition, most pharmacological
interventions are not as effective as non-pharmacological interventions once wounds begin
granulating towards the healing stage when pruritus is more concerned (Goutos, 2013).
Administering topical agents in both healing and healed stages of wounds are beneficial
to the population with PBP according to several researches (Campanati et al., 2013; Lewis et al.,
2012; Nedelec, Rachelska, Parnell, & LaSalle, 2012; Ogawa & Hyaku-soku, 2008). Campanati
et al. (2013) reported ozonated oil and hyaluronic acid gel applied to burn associated wounds
decreased PBP. The study by Ogawa and Hyaku-soku (2008) revealed medilixir and mugwort
lotion were effective in relieving PBP. Mugwort lotion is consisted of mugwort extract, l-
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menthol, absolute ethanol, and distilled water. Provase® (Dimethicone) cream was also reported
in relieving PBP (Nedelec et al., 2012). Medilixir® (a beeswax and herbal oil cream) reduced
PBP when applied to burn associated wounds (Lewis et al., 2012). Moisturizing body shampoo
showed effective decrease of PBP (Ratcliff et al., 2005). Botulinum toxin (Botox®) is shown to
reduce PBP effectively by using one time dose in those who failed in managing PBP with
conventional therapies (Akhtar & Brooks, 2012).
Non-pharmacological Interventions
Another thirteen out of 26 articles reported non-pharmacological methods in relieving
PBP. Examples of effective non-pharmacological interventions included: massage therapy, laser
therapy (either regular or low level laser [LLLT]), transcutaneous electrical nerve stimulation
(TENS), triamcinolone acetonide phonophoresis (TAP), muscle relaxation, silicone gel sheeting
(SGS), pressure garment (Unna boot®), and nanocrystalline silver (Acticoat®). Most nonpharmacological interventions showed anti-pruritic effects specifically during the healed stage of
burn wounds, whereas massage and Benson muscle relaxation therapy can be used regardless of
the stage of healing.
The study by Gurol, Polat, and Akcay (2010), a single RCT, exhibited massage therapy to
intact skin decreased PBP among adolescent burn patients at the early phase of burn injury (prehealing stage). Experimental group’s itching level (range: 0-10) was averagely 6.1 before the
message therapy and then significantly decreased to 2.5 whereas control group’s average itching
level slightly decreased from 5.59 to 5.50 (Gurol et al., 2010). They also showed this therapy
significantly reduced anxiety and pain in the experimental group (Gurol et al., 2010). There are
three other studies showing effective reduction in PBP with message therapy applied directly to
healed burn wounds (Cho et al., 2014; Field et al., 2000; Roh, Cho, Oh, & Yoon, 2007). The
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study by Cho et al. (2014), a RCT, showed massage therapy led to significant improvement in
pain and itching as well as positive changes in scar characteristics. Another RCT is the study by
Field et al. (2000) reporting massage therapy resulted in the significant decrease in itching, pain,
depression and anxiety among those with PBP. Roh et al. (2007) conducted a RCT
demonstrating massage therapy improved pruritus, scar status, and depression among burn
patients. The study by Farahani, Hekmatpou, and Khani (2013), a Quasi-experimental study
reported Benson muscle relaxation therapy lowered PBP in any healing stages in burn Patients.
The researchers supported Benson muscle relaxation therapy was significantly effective in
relieving the pain, pruritus, and vital signs of patients suffering from burns (Farahani et al.,
2013).
Gaida et al. (2003) showed LLLT significantly decreased PBP. The study by Hultman,
Edkins, Wu, Calvert, & Cairns (2013) demonstrated regular laser therapy relieved PBP
effectively as well. The experimental study by Hultman et al. (2013) was designed as pretestposttest. The study’s control group was the intact skin of participants and the experimental
group was the participants’ burn wounds (Hultman et al., 2013).
TENS was proven to reduce itching in the patients suffering from PBP (Hettrick, 2014;
Whitaker, 2001). The pilot RCT by Hettrick (2014) stated TENS was significantly effective in
PBP reduction when TENS was provided an hour per day for three weeks. The case study by
Whitaker (2001) revealed receiving TENS for nine hours a day for two weeks relieved pruritus
that resulted in no need of treatment for itching after two weeks. In detail, PBP decreased from
100% to 0% after two week of TENS therapy (Whitaker, 2001).
The RCT by Waked, Nagib, and Ashm (2013) reported TAP reduced PBP as effectively
as TENS did. In their study, 20 patients received TAP and another 20 students received TENS
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(Waked et al., 203). The effectiveness in relieving PBP in both groups was shown to be
significantly positive, but there was no difference regarding the relief of PBP between two
groups (Waked et al., 2013).
A case study by Brooks, Phang, and Moazzam (2007) demonstrated two weeks of
applying nanocrystalline silver to unhealed wound reduced PBP in five cases with different burn
associated wound sizes. This intervention was reported to decrease the pruritus from 7.4 to 3.1
of visual analog scale (VAS), which means significant reduction in PBP (Brooks et al., 2007).
The researchers also reported nanocrystalline silver improved wound healing as well as reduction
in PBP (Brooks et al., 2007).
Wearing SGS was reported as the effective way in reducing PBP (Li-Tsang, Lau, Choi,
Chan, & Jianan, 2006; Li-Tsang, Zheng, & Lau, 2010). The RCT by Li-Tsang et al. (2006)
showed experimental group had significantly decreased itching compared to the control group.
The study demonstrated participants wearing SGS also had significant improvement in scar
thickness and pliability (Li-Tsang et al., 2006). Another RCT by Li-Tsang et al. (2010) showed
wearing pressure garment significantly reduced pruritus as well as SGS did. The study also
revealed that wound was significantly improved when both pressure garment and SGS were
applied together (Li-Tsang et al., 2010).
Development of the PBP Relief Protocol
The outcome of this literature review was synthesized according to the best evidence
based outcomes from both combined pharmacological and non-pharmacological interventions.
Accordingly, a PBP relief protocol was developed (Figure 2). This protocol was designed
according to the three different stages of wound healing: pre-healing (no granulation tissue),
healing (partly granulated tissue), and healed stages (scar formation) with recommended dosages
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and period for each intervention (Table 2). Non-pharmacological interventions were
recommended before pharmacological interventions considering established effectiveness and
possible adverse effects of pharmacological interventions.
Utilization of the PBP Relief Protocol
Each stage of wound healing can be managed by both non-pharmacological and
pharmacological interventions. Non-pharmacological interventions are less invasive and should
be considered as the primary intervention. On the other hand, pharmacological interventions are
more invasive and should be used only as a supplement to potentiate the therapeutic effect of
non-pharmacological interventions or to minimize possible adverse effects of pharmacological
interventions.
Since non-pharmacological interventions are versatile and can be combined with other
non-pharmacological and pharmacological interventions, non-pharmacological interventions
should be considered first. So pharmacological interventions are recommended only when nonpharmacological interventions are ineffective. In this case, only single pharmacological
intervention is initially to be used with any non-pharmacological interventions (Table 2). When
single pharmacological intervention is not effective, two or three different medication can be
combined. For example, at pre-healing stage, all non-pharmacological interventions (both
massage and Benson muscle relaxation therapy) can be used with one or more pharmacological
interventions (pregabalin alone, pregabalin and two antihistamines, gabapentin alone, gabapentin
and one or two H1 blockers, or a combination of H1 and H2 blockers) (Figure 2).
Discussion
This post burn pruritus protocol is the first evidence based protocol that uses nonpharmacological interventions as the primary method of choice to reduce PBP. Non-
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pharmacological and Pharmacological interventions for PBP have been identified and presented
in an easily understood protocol to improve patient outcomes and clinical practice.
Recommended dosage and duration of each intervention are included to clearly guide clinicians
(Table 2). A rehabilitation nurse may utilize this protocol by encouraging patients to use nonpharmacological interventions as a primary intervention for PBP in collaboration with
interdisciplinary team members.
This protocol was drawn from mostly RCTs which are the level II of evidence. However,
each individual therapy of non-pharmacological interventions has one to three literature support
(Table 2). Accordingly, clinicians need to validate the efficiency of this suggested protocol by
conducting a pilot study for the patients suffering from PBP. Their pilot study should
demonstrate this protocol significantly relieved PBP. The pilot study researchers can use the 5-D
Itch Scale (Figure 3), the visual analog scale (Figure 4), and the Itch man scale as valid and
reliable instruments for PBP (Elman, Hynan, Gabriel, & Mayo, 2010). In addition, they need to
validate the efficacy of this PBP protocol by determining if the protocol: 1) relieved pruritus
discomfort; 2) reduced cognitive dysfunctions such as low concentration, agitation, anxiety,
and/or flat affect; and 3) increased quality of life (QoL).
Conclusion
This suggested protocol was developed to use non-pharmacological interventions
primarily and pharmacological interventions as a secondary treatment. Accordingly, this
protocol can be beneficial to patients by minimizing possible adverse effects of oral medications.
Another benefit of this protocol is to provide a wide range of interventions with recommended
treatment dosages and period. The rehabilitation nurse needs to play a key role in collaborating
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Figure 1. Flow diagram for selection of studies

Figure 2. Post Burn Pruritus Relief Protocol

Figure 3. 5 – D ITCH SCALE (Adopted from Elman, Hyman, Gabriel, & Mayo, 2010)

Figure 4. Visual Analog Scale (Adapted from Elman et al., 2010)

Table 1. Table of Evidence

No
1

Authors
(year)
Ahuja &
Gupta
(2012)

Setting/
Participants
Outpatient
setting /
80 Adult Burn
pts

Ahuja et al.
(2010)

Department of
burns /
20 Burn pts w/
12-70 yrs old

RCT /

Akhtar &
Brooks
(2012)

Outpatient
setting/
8 pts w/failure
of managing
PBP in the
past
Setting not
stated/
17pts w/ 1060yrs of age

Prospective& All healed areas after 2ndexperimental 3rd degree burns
study/
One time
Double
blind,
Crossover
trial/16days

Partial thickness & any %
of TBSA burn.
Not described in wound
healing stage

Inpatient &
outpatint
settings/
5cases

Case study/
2weeks

TBSA of 7-65% w/
unhealed burn wound

2

3

Baker et al.
(2001)
4

5

Study Design
/ Intervention
Characteristics of
Time
Burn Wound
RCT /
TBSA > 5%, 2nd degree
burns, & wound either in
28days
healing or healed

Brooks et
al.
(2007)

28days

TBSA > 5%, 2nd degree
burns, over 80% of wound
epithelialized or healed

Itching
assessment Tool
Study Result & Limitations
VAS
Pregabalin alone or combined w/antihistamine
→ ↓ PBP
Adding antihistamines does not decrease PBP
Limitation: The study did not define end point of
anti-pruritic therapy.
VAS
Gabapentin alone or combination w/cetirizine →
↓ PBP
Certirizine only does not decrease PBP
Limitaion: too small sample size, limited period
of data collection, graft size more than 1%
excluded, single site study.
VAS
Botox → ↓ PBP in population who failed in
managing PBP w/ conventional therapies.
50% had no PBP within 2wks after Botox & no
itching up to 9months after treatment.
Limitation: Difficult to expect who will require
multiple injections to control their symptoms.
VAS
Combining H1 & H2 antagonists: more effective
in ↓PBP than H1 antagonist alone during the
first stage of treatment.
More effective to treat PBP w/ scheduled
medication than as needed medication
Limitation: Small size of sample, High attrition
rate (47%)
VAS
2-week Acticoat® application is effective in
↓PBP
Limitation: This study did not indicate the
condition of wounds whether they were healed
or unhealed. However, it is assumed they were
unhealed or in the healing process because
acticoat is used for unhealed wounds in current

No

Authors
(year)

10

11

Characteristics of
Burn Wound

Itching
assessment Tool

Unclear
setting/
30pts

Non-RCT /
12weeks

2nd degree burns in healing
stage

unknow
n

Cho et al.
(2014)

Rehabilitation
hospital/
146pts w/
hypertrophic
scars

RCT/
Average
34.69days

All healed burn wound
(scar)

VAS

Faraha-nil
et al.
(2013)

Inpatient
setting/
110pts

Quasiexperimental
study /
1month

VAS

Field et al.
(2000)

Outpatient
burn center/
20pts w/ PBP

RCT /
5weeks

2nd degree burn wounds
Stage of wound healing not
clear-possibly not healed
wound considering
population
Healed burn wound

Gaida et al.
(2003)

Outpatient
setting/
19burn pts w/
scars

Pretestposttest
design /
8weeks

Healed burn wound (scar)

VAS

Goutos et
al.
(2010)

Inpatient
setting/
91burn pts

Cohort,
observational
studies/

Partial to full thickness
burn injury.
Healing stages not

VAS /
Itch
Man

7

9

Study Design
/ Intervention
Time

Campanati
et al. (2013)
6

8

Setting/
Participants

VAS

practice.

Study Result & Limitations

Ozonated oil & hyaluronic acid: Same effect in
↓PBP 12-week topical application.
Ozonated oil: more effective than hyaluronic
acid in preventing post hyperpigmentation.
Limitation: Lack of a histological comparison
b/w two agents.
Massage therapy ↓ in pain, pruritus, & scar
characteristics in patients.
Limitation: Massage given only for short period
(average: 34.7days), so long-term effects not
identified. Evolution of hypertrophic scar not
considered.
20-minute Benson muscle relaxation: effective
in ↓PBP.
Limitation: No explanation if other methods to
reduce pruritus along with relaxation tx. No
explanation of frequency of relaxation tx.
Massage therapy decreased itching, pain,
depression & anxiety in burn population w/
severe itching.
Limitation: Further study needed for larger
sample & long term use of massage therapy.
LLLT decreased pain & pruritus among all
participants.
Limitation: Further study needed w/ higher
number of sample & control site from different
people rather than each person w/ different sites.
Monotherapy in PBP: gabapentin monotherapy
has more effective than chlorpheniramine.
Polytherapy in PBP: Combination of gabapentin,

No

Study Design
/ Intervention
Characteristics of
Time
Burn Wound
Intervention
specified.
time not
specified

Authors
(year)

Setting/
Participants
(50-1st part,
41-2nd part of
the study)

Gurol et al.
(2010)

Inpatient
setting/
63adolescent
burn pts

Experimental
study/
5weeks

Hettrick
(2004)

Outpatient
clinic/
20pts w/ age
of 18-75yrs

RCT
(Pilot study)
/ 3weeks

Hultman et
al.
(2013)

Outpatient
sugical center/
147burn pts w/
hypertrophic
burn scars

Cohort
study/
6months

Jung et al.
(2009)

Inpatient
rehabilitation /
19pts treated
for burn injury

Retrospectiv
e,
experimental
study/
2weeks

12

13

14

15

Itching
assessment Tool
Study Result & Limitations
Scale
cetirizine, & cyproheptadine is more effective
than combination of 3 antihistamines.
Limitation: Needs further studies incorporating
long term f/u of comparing peripherally &
centrally acting agents in late phases of wound
healing.
2nd-3rd degree burn wound. VAS
15-minute massage twice per week for 5weeks
Healing stage not specified.
applied to healthy skin around wounds & surface
of wound decreased PBP in adolescent
population.
Limitation: Small sample size & The study did
not specify wound conditions whether it is
healed or not. – it is assumed that not all wound
are healed according to the fact some pts were
getting standard tx including pain & they were
enrolled in the study right after admission.
nd
rd
2 to 3 degree recently
VAS
TENS reduced PBP.
healed burn wound
Limitation: Hard to generalized to population
<18 or > 75yrs of age. Can’t apply to
inflammatory or proliferative stage of wound
healing.
All healed burn wounds
VAS
Laser therapy decreased pain, pruritus, pliability,
& paresthesia in the population.
Limitation: Long-term effect is uknown, Scar
component unspecified, Evaluator bias not
excluded, No control group exists, & Order of
different lasers not examined.
Healed burn wounds
VAS
With Naltrexone therapy, 14 pts reported
improvement in itching, 5 pts reported no
change in itching, & 7 pts had side effects.
Limitation: Small sample size to generalize,
uncertain to use Naltrexone as the first line of tx.

No

16

17

18

19

20

21

Authors
(year)
La Salle et
al.
(2007)

Setting/
Participants
Inpatient &
outpatient
settings/
13burn pts
age of 19-78

Lewis et al.
(2012)
Li-Sang et
al.
(2006)

Inpatient
setting /
52burn pts,
mean age 35
Outpatient
clinic/
45burn pts

Li-Tsang et
al.
(2010)

Study Design
Itching
/ Intervention
Characteristics of
assessTime
Burn Wound
ment Tool
Study Result & Limitations
Experimental TBSA of 7-70% & all
VAS
Naltrexone ↓PBP, frequency & duration of
study/
grafted burn areas.
itching.
2weeks
Healing stages not specified
Limitation: Small sample size, itch intensity or
qualification of scratching activity to be
frequently measured, broader range of burn pts,
long term f/u, & a placebo controlled tx group
needed.
RCT,
Mean TBSA:7.2%, mostly
VAS
Medilixir was more effective to minimize PBP
Pilot study /
partial thickness burn
than aqueous cream.
24hours
wound & newly healed scar
Limitation: Small sample size
RCT /
6months

Post traumatic hypertrophic
scars

participant’s
routine area /
104burn pts

RCT /
6months

Burn scars

Mendham
(2004)

Inpatient
setting /
35pediatric
wound pts

Experimental
study/
4weeks –
18months

Burn wounds and skin loss
from meningitis.
Not healed wound

Nedelec et
al.
(2012)

Not clear /
18pts having
PBP treated in
the hospital

RCT,
Pilot study /
4weeks

All healed burn wounds
(scars)

VAS

SGS was effective to reduce thickness, pain,
itchiness, & pliability of the severe hypertrophic
scar.
Limitation: Generalization issue due to small
size sample & all Chinese participants. Only 16
burn scars out of 45 scars – can the result be
applied to specifically to burn scar pts?
VAS
SGS ↓pain & ↓pruritus than ↓scar thickness.
CTG & PG showed improvement in scar
thickness after 6-month intervention (CTG>PG).
Limitation: High drop-rate of participants (19%)
Unkno
Gabapentin ↓itching in healing wound &
wn
↓antihistamine intake in pediatric population.
Limitation: Gabapentin tx needs cautions for
worsening behaviors in pediatric population &
RCT is necessary.
Yosipo- Provase ↓PBP in frequency & episode of itch, &
vitch’s
duration of itch.
question Limitation: Small pilot study, single center &
-naire
convenience population, short period of data
collection (4wks), & no classification b/w acute
& chronic pruritus in post burn population.

No

22

Authors
(year)
Ogawa &
Hyakusoku (2008)

Ratcliff et
al.
(2005)

Setting/
Participants
Inpatient
setting/
14pts w/
hypertrophic
scars from
burns
Inpatient
setting /
286burn
children

Study Design
/ Intervention
Characteristics of
Time
Burn Wound
Prospective,
All healed burn wounds
Cohort study (scars)
/ 2months

Itching
assessment Tool
Study Result & Limitations
VAS
Mugwort lotion decreased itching & sleep
disturbance.
Limitation: Need to continue to evaluate effects
& mechanism of Mugwort lotion. Further
studies needed for evaluating this lotion.

Retrospective chart
review /
Varied

All burn wounds
: Various wound stages

Itch
Man
Scale

23

24

25

26

Roh et al.
(2007)

Outpatient
clinic/
35burn pts

Pretest –
posttest /
3months

Burn scars from partial or
full thickness burns on
forearm or hand

Itch
man
Scale

Waked et
al.
(2013)
Whitaker
(2001)

Inpatient
setting /
40burn pts
Inpatient
setting /
One case

RCT/
1month

2nd & 3rd degree burn
wounds, 10-15%TBSA. –
All Healed scars
Healed 70%TBSA flame
burn wound (scar)

5-D Itch
scale

Case study /
2weeks

VAS

Management protocols for pain, anxiety, stress,
& iching in pediatric population offers data to
reduce burn related symptoms in the future.
i.e: Itching management protocol for children;
1)Moisturizing body shampoo, lotions, & topical
ointments (not hydrocortisone creams)
2)Diphenhydramine 1.25mg/kg/dose po Q 6h
3)If itch remains poorly controlled, subsequently
add hydroxyzine 0.6mg/kg/dose po q 6h, then
cyproheptadine 0.1mg/kg/dose q6h so that one
of the medications is given q2hrs
Limitation: Possibility of incomplete data due to
study design
SRMT decreased PBP in burn victims with scars
on forearms or hands.
Limitation: Small sample size & needs more
reliable & objective burn-scar assessment tools.
TAP was as useful as TENS to reduce PBP
Limitation: No control group in the study &
small sample noted.
2 weeks of TENS was effective in ↓PBP.
Day #1: 62.5% decreased in itching within 4hrs
of application.
Day #2: 88% decreased within 4hrs of
application.
Day #3: No itching within 4hrs of application.
Limitation: More case studies or full-scale study

No

Authors
(year)

Setting/
Participants

Study Design
/ Intervention
Time

Characteristics of
Burn Wound

Itching
assessment Tool

needed.

Study Result & Limitations

Notes. CTG = combined pressure therapy and silicone gel sheeting group; h = hour; hrs = hours; H1 = histamine 1; H2 = histamine 2; LLLT = low level laser
therapy; PBP = post burn pruritus; PG = pressure therapy group; po = orally; pts = patients; Q = every; RCT = randomized controlled trial; SGS = silicone gel
sheeting; SRMT = skin rehabilitation massage therapy; TAP = triamcinolone acetonide phonophoresis; TBSA = total body surface area; TENS =
transcutaneous electrical nerve stimulation; VAS = Visual Analog Scale; wks = weeks; w/ = with; ↓= decreased.

Table 2. Post Burn Pruritus Relief Protocol Guideline (Recommended Dosage)
Wound Stage
Pre-healing
stage

Treatment Plan
Massage to intact skin
Benson Muscle Relaxation therapy
Pharmacological treatment
- Pregabalin alone
- Pregabalin & two antihistamines
- Gabapentin alone
- Gabapentin & H1 blocker
- Gabapentin & two H1 blockers
- Combination of H1 & H2
blockers

Healing stage

Naltrexone (supplemental
pharmacological treatment)
All treatments for pre-healing stage
& Topical agents (Ozonated oil or
Hyaluronic acid gel 0.2%)

Healed stage

Benson muscle relaxation

- 150-300mg/day (divided by 2 or 3 times)
- Pregabalin (same dose),
Cetirizine 10-20mg/day (one or twice a day), &
Pheniramine 25mg/day before sleep
- 300-900mg/day (adult), 5-10mg/kg/day (child)
- Gabapentin (same dose) & Cetirizine 10-20mg/day
- Gabapentin & Cetirizine (same doses) &
Cyproheptadine 4mg every 6hours
- Cetirizine: 20mg/day (adult) & 10mg/day (pediatric
patient), &
Cimetidine: 1200mg/day, divided by 4 (adult),
30mg/kg/day, divided by 4 (child)
25-50mg/day before sleep for 2weeks (15, 16)

TENS
TAP
SGS

Ozonated oil 2drops/cm²once a day or
Hyaluronic acid gel ½ finger tip/cm²daily
For 12 weeks or as needed (6)
Same dose as above (8)
15-30minutes, 1-3times/week for 5-12weeks
(7, 9, 24)
for 2weeks (5)
LLLT: 2times/week for 8weeks (10)
Regular laser therapy: once per month for 6 month
(14)
Once a day for 2-3weeks (13, 26)
3times/week for 1month (25)
Wear 12-24hours/day for 6months (18, 19)

Pressure garments

Apply as needed (19)

Topical agents
- Medilixir
- Mugwort lotion
- Provase
- Ozonated oil
- Hyaluronic acid gel 0.2%

- Once daily for 2weeks (17)
- 2 times/day for 2months (22)
- 3 times/day for 4weeks (21)
- 2drops/cm²once daily (6)
- ½finger tip/cm² daily (6)

Botulinum toxin

One time dose (3)

Massage to healed wound

Nanocrystalline silver
LLLT or
regular Laser Therapy

After failure
with above

Recommended Dosage
(refer to article No. in Table 1)
15minutes/day, 2days/week, 5weeks or as needed.
(12)
20minutes daily for 1month or as needed
(8)
(1, 2, 4, 11, 20, 23)

